Jake Fitzgerald Appointed As Chief Executive Officer of Pure Tech Scientific Llc By Iron Path Capital

Aug 19, 2024•12 months ago

Position

Chief Executive Officer

Company

PureTech Scientific

Jake Fitzgerald

BelleBiotechnologyManufacturing

Description

Iron Path Capital announced the appointment of Jake Fitzgerald as Chief Executive Officer of PureTech Scientific LLC, a global leader in glycolic acid synthesis and technology. Fitzgerald brings a wealth of industry knowledge from his previous roles and is expected to lead PureTech into the next era of opportunities and success.

Company Information

Company

PureTech Scientific

Location

Belle, West Virginia, United States

About

PureTech Scientific, formerly Chemours Glycolic Acid Division, is the global leader in organic synthesis of ultra-high purity alpha hydroxy acids for the Life Sciences and Specialty Chemical industries, and the sole manufacturer in the Americas. With over 85 years of operating experience and a commitment to reducing our carbon footprint, we are dedicated to world-class products, innovations, and customer support for a healthier and safer world.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months